- August 12, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Tussigon
Synonyms :
hydrocodone and homatropine
Class :
Narcotic Combos, Antitussives
Dosage Forms & Strengths
Tablet: Schedule II
5mg/1.5mg
oral solution: Schedule II
(5mg/1.5mg)/5mL
5 mg/1.5 mg orally every 4-6 hours
Dosage Forms & Strengths
Tablet: Schedule II
5mg/1.5mg
oral solution: Schedule II
(5mg/1.5mg)/5mL
5 mg/1.5 mg orally every 4-6 hours
Concomitant administration with benzodiazepine agonists may enhance the risk of extreme sedation, respiratory depression, and coma
Concomitant administration with benzodiazepine agonists may enhance the risk of extreme sedation, respiratory depression, and coma
Concomitant administration with benzodiazepine agonists may enhance the risk of extreme sedation, respiratory depression, and coma
may have an increased Effect of CNS depressant when combined with serotonergic opioids
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may reduce the analgesic effect of Opioid agonists
may reduce the analgesic effect of Opioid agonists
may reduce the analgesic effect of Opioid agonists
may reduce the analgesic effect of Opioid agonists
may reduce the therapeutic effect
may reduce the therapeutic effect
may reduce the therapeutic effect
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
Actions and Spectrum:
Actions:
Spectrum:
Adverse drug reactions:
Frequency not Defined
Angina
arrhythmias
cardiac arrest
myocardial infarction
QT-interval prolongation
ventricular tachycardia
Eczematoid dermatitis
Increased IOP
Follicular conjunctivitis
Edema
Vascular congestion
Exudate
Black Box Warning:
none
Contraindication / Caution:
Contraindications:
Caution:
Pregnancy warnings:
Pregnancy category: N/A
Breastfeeding warnings:
The release of the drug into the human breastmilk is unknown
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits
Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: hydrocodone/homatropine
Why do we use hydrocodone/homatropine?
hydrocodone/homatropine is a combination medication used for the symptomatic relief of cough. Here are the main reasons why hydrocodone/homatropine is used: